← Back to events
ActiveBusiness

Foghorn Therapeutics is cutting 40% of its workforce after Eli Lilly ends cancer drug partnership

Photo: Quartz

What happened

The companies are scrapping two collaborative cancer programs and don't anticipate any further joint projects

Summary assembled by rule from the sources below

Sources